[抗结核化合物的晶体结构。3. 丙基-2-硫代氨基甲酰基-4-吡啶的晶体结构] - Suppr | 超能文献

[Crystalline structure of antitubercular compounds. 3. Crystalline structure of propyl-2-thiocarbamoyl-4-pyridine].

作者信息

Colleter J C, Gadret M, Goursolle M

出版信息

Acta Crystallogr B Struct Crystallogr Cryst Chem. 1970 Oct 15;26(10):1510-8. doi: 10.1107/s0567740870004417.

DOI:10.1107/s0567740870004417

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

[Crystalline structure of antitubercular compounds. 3. Crystalline structure of propyl-2-thiocarbamoyl-4-pyridine].[抗结核化合物的晶体结构。3. 丙基-2-硫代氨基甲酰基-4-吡啶的晶体结构]

Acta Crystallogr B Struct Crystallogr Cryst Chem. 1970 Oct 15;26(10):1510-8. doi: 10.1107/s0567740870004417.

2

Construction and functionalization of fused pyridine ring leading to novel compounds as potential antitubercular agents.构建并官能化融合吡啶环，得到新型化合物，作为潜在的抗结核药物。

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4629-35. doi: 10.1016/j.bmcl.2012.05.096. Epub 2012 Jun 5.

3

[Crystalline structure of antitubercular compounds. I. Crystalline structure of the hydrochloride of ethionamide].[抗结核化合物的晶体结构。I. 乙硫异烟胺盐酸盐的晶体结构]

Acta Crystallogr B Struct Crystallogr Cryst Chem. 1968 Apr 15;24(4):513-9. doi: 10.1107/s056774086800275x.

4

Antitubercular activity of substituted 5-oxo-1-thiocarbamoyl-3-pyrazoline-4-alkanoic acid derivatives.取代的5-氧代-1-硫代氨基甲酰基-3-吡唑啉-4-链烷酸衍生物的抗结核活性

J Pharm Sci. 1975 Jun;64(6):1057-8. doi: 10.1002/jps.2600640646.

5

[Crystalline structure of antitubercular compounds. II. Crystalline structure of hydrobromide of ethionamide. Comparison with that of the hydrochloride of ethionamide].[抗结核化合物的晶体结构。II. 乙硫异烟胺氢溴酸盐的晶体结构。与乙硫异烟胺盐酸盐的晶体结构比较]

Acta Crystallogr B Struct Crystallogr Cryst Chem. 1968 Apr 15;24(4):519-25. doi: 10.1107/s0567740868002761.

6

Metal complexes of carboxamidrazone analogs as antitubercular agents. 1. Synthesis, X-ray crystal-structures, spectroscopic properties and antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv.作为抗结核药物的羧脒腙类似物的金属配合物。1. 合成、X射线晶体结构、光谱性质及对结核分枝杆菌H(37)Rv的抗分枝杆菌活性。

J Inorg Biochem. 2002 Jun 7;90(3-4):127-36. doi: 10.1016/s0162-0134(02)00406-3.

7

Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.一些新型吲哚和吡啶基1,3,4-恶二唑衍生物作为潜在抗结核药物的合成、生物学评价及分子对接研究

Bioorg Med Chem Lett. 2016 Apr 1;26(7):1776-83. doi: 10.1016/j.bmcl.2016.02.043. Epub 2016 Feb 16.

8

Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.N-(2-苯氧基)乙基咪唑并[1,2-a]吡啶-3-甲酰胺类衍生物的设计、合成与抗结核活性研究。

Eur J Med Chem. 2019 Sep 15;178:715-725. doi: 10.1016/j.ejmech.2019.06.038. Epub 2019 Jun 14.

9

The antitubercular properties of a series of thiols and sulphides.一系列硫醇和硫化物的抗结核特性。

Br J Pharmacol Chemother. 1960 Dec;15(4):485-95. doi: 10.1111/j.1476-5381.1960.tb00268.x.

10

Synthesis and antitubercular activities of substituted benzoic acid N'-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides.取代苯甲酸 N'-(取代亚苄基/呋喃-2-亚甲基)-N-(吡啶-3-甲酰基)腙的合成及抗结核活性。

Eur J Med Chem. 2010 Dec;45(12):6085-9. doi: 10.1016/j.ejmech.2010.08.030. Epub 2010 Aug 18.

引用本文的文献

1

Molecular Crystal Forms of Antitubercular Ethionamide with Dicarboxylic Acids: Solid-State Properties and a Combined Structural and Spectroscopic Study.抗结核药物乙硫异烟胺与二元羧酸的分子晶体形式：固态性质以及结构与光谱联合研究

Pharmaceutics. 2020 Aug 28;12(9):818. doi: 10.3390/pharmaceutics12090818.

2

4-Thio-carbamoylpyridin-1-ium iodide.4-硫代甲酰氨基吡啶碘化物。

Acta Crystallogr Sect E Struct Rep Online. 2014 Feb 22;70(Pt 3):o340-1. doi: 10.1107/S1600536814003511. eCollection 2014 Mar 1.